8 Sawicki M, Lecercle D, Grillon G, et al. Bisphosphonate sequestering agents. Synthesis and preliminary evaluation for in vitro and in vivo uranium(VI) chelation[J]. European Journal of Medicinal Chemistry, 2008, 43:2768-2777.
[9]
9 Henge-Napoli M H, Stradling G N, Taylor D M(Eds). Decorporation of radionuclides from the human body[M].Ashford, UK: Nuclear Technology Publishing, 2000.
[10]
10 Gama S, Gil M, Gano L, et al. Combined chelation of bi-functional bis-hydroxypiridinone and mono-hydroxypiridinone: Synthesis, solution and in vivo evaluation[J]. Journal of Inorganic Biochemistry, 2009, 103:288-2980
[11]
11 Stradling G N. Decorporation of actinides: a review of recent research[J]. Journal of Alloys and Compounds, 1998, 271-273:72-77.
[12]
12 Ansoborlo E, Amekraz B, Moulin C, et al. Review of actinide decorporation with chelating agents[J]. C. R. Chimie, 2007, 10:1010-1019.
[13]
13 Leydier A, Lecercle D, Pellet-Rostaing S, et al. Sequestering agent for uranyl chelation: a new family of CAMS ligands[J]. Tetrahedron, 2008, 64:6662-6669.
[14]
14 Van Horn J D, Huang H. Uranium(VI) bio-coordination chemistry from biochemical, solution and protein structural data[J]. Coordination Chemistry Reviews, 2006, 250:765-775.
16 Durbin W, Kullgren B, Ebbe N,et al. Chelating agents for Uranium(VI):2.efficacy and toxicity of tetradentate catecholate and hydroxypyridinonate ligands in mice[J].Healthy Physics,2000,78(5):511-521.